Burning Rock Biotech Statistics Share Statistics Burning Rock Biotech has 1.08M
shares outstanding. The number of shares has increased by -89.49%
in one year.
Shares Outstanding 1.08M Shares Change (YoY) -89.49% Shares Change (QoQ) -89.5% Owned by Institutions (%) 20.39% Shares Floating 1.07M Failed to Deliver (FTD) Shares 3 FTD / Avg. Volume 0.01%
Short Selling Information The latest short interest is 39.16K, so 0.38% of the outstanding
shares have been sold short.
Short Interest 39.16K Short % of Shares Out 0.38% Short % of Float 0.53% Short Ratio (days to cover) 2.83
Valuation Ratios The PE ratio is -0.15 and the forward
PE ratio is null.
Burning Rock Biotech's PEG ratio is
0.
PE Ratio -0.15 Forward PE n/a PS Ratio 0.1 Forward PS n/a PB Ratio 0.09 P/FCF Ratio -0.52 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Burning Rock Biotech.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.92,
with a Debt / Equity ratio of 0.09.
Current Ratio 2.92 Quick Ratio 2.71 Debt / Equity 0.09 Debt / EBITDA -0.19 Debt / FCF -0.53 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $765.31K Profits Per Employee $-514.28K Employee Count 674 Asset Turnover 0.58 Inventory Turnover 2.85
Taxes Income Tax 5.88M Effective Tax Rate -1.73%
Stock Price Statistics The stock price has increased by 0.29% in the
last 52 weeks. The beta is 0.84, so Burning Rock Biotech's
price volatility has been higher than the market average.
Beta 0.84 52-Week Price Change 0.29% 50-Day Moving Average 4.43 200-Day Moving Average 4.83 Relative Strength Index (RSI) 60.95 Average Volume (20 Days) 41,414
Income Statement In the last 12 months, Burning Rock Biotech had revenue of 515.82M
and earned -346.63M
in profits. Earnings per share was -341.5.
Revenue 515.82M Gross Profit 362.4M Operating Income -357.56M Net Income -346.63M EBITDA -270.23M EBIT -322.43M Earnings Per Share (EPS) -341.5
Full Income Statement Balance Sheet The company has 519.85M in cash and 52.32M in
debt, giving a net cash position of 467.53M.
Cash & Cash Equivalents 519.85M Total Debt 52.32M Net Cash 467.53M Retained Earnings -4.2B Total Assets 854.72M Working Capital 509.09M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -92.26M
and capital expenditures -5.98M, giving a free cash flow of -98.24M.
Operating Cash Flow -92.26M Capital Expenditures -5.98M Free Cash Flow -98.24M FCF Per Share -95.43
Full Cash Flow Statement Margins Gross margin is 70.26%, with operating and profit margins of -69.32% and -67.2%.
Gross Margin 70.26% Operating Margin -69.32% Pretax Margin -66.06% Profit Margin -67.2% EBITDA Margin -52.39% EBIT Margin -69.32% FCF Margin -19.04%
Dividends & Yields BNR does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for BNR.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on May 15, 2024. It was a
backward
split with a ratio of 1:10.
Last Split Date May 15, 2024 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -6.38 Piotroski F-Score 3
